CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma – Markets Insider
Medical Xpress |
CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma
Markets Insider ATLANTA, Dec. 10, 2017 /PRNewswire-USNewswire/ — For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology (ASH … Landmark CAR–T cancer study published |
